MYH7 and left ventricular hypertrophy: In contrast, an earlier meta–analysis comprising 18 studies with 2459 patients found no differences in terms of symptoms, age of onset and grade of left ventricular hypertrophy between MYBPC3 and MYH7 mutation carriers [36].